Chemotherapy and Radiotherapy in Gynaecological Cancer
Chemotherapy kills cancer largely by damaging tumour DNA and preventing replication. It can be used for cure, symptom control, to reduce risks of recurrence or to make other cancer treatments such as radiotherapy more effective. Radiotherapy is the use of ionising radiation to kill cancers. It is usually given in multiple treatments (fractions) to minimise damage to normal tissue. Both modalities are widely used in the treatment of gynaecological cancers. This chapter deals with litigation related to their usage.
KeywordsChemotherapy Radiotherapy Gynaecological cancer Complications Prognosis
- 5.Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with Stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Postoperative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404–11.CrossRefPubMedGoogle Scholar
- 9.The International Collaborative Ovarian Neoplasm (ICON) group. Paclitaxel plus carboplatin versus standard chemotherapy with either single agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet. 2002;360:505–15.CrossRefGoogle Scholar
- 13.Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynaecol. 1986;68(6):733–40.Google Scholar